FIELD: medicine. SUBSTANCE: method involves administering intravenous system injection of solved ozone once per 3-15 days in equal amounts from 0.1 to 0.7 mg per 1 kg of patient body weight in addition to applying commonly used antituberculosis chemotherapy and phathogenetic means. EFFECT: enhanced effectiveness of treatment; accelerated treatment course. 6 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS | 1993 |
|
RU2085218C1 |
| PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
| METHOD FOR TREATING HUMAN TUBERCULOSIS | 2002 |
|
RU2238091C2 |
| PREPARATION FOR MAINTENANCE THERAPY OF GASTRO-INTESTINAL DISEASES IN CASE OF PROLONGED ANTIBACTERIAL TREATMENT | 2005 |
|
RU2302254C2 |
| METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS WITH ACCOMPANYING NON-SPECIFIC BRONCHITES | 2013 |
|
RU2526121C1 |
| METHOD FOR EARLY PREDICTION OF CLINICAL EFFECTIVENESS IN PATIENTS WITH NEWLY DIAGNOSED INFILTRATIVE PULMONARY TUBERCULOSIS | 2010 |
|
RU2464577C2 |
| METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS MULTIPLE DRUG-RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2018 |
|
RU2687743C1 |
| METHOD FOR TREATING PULMONARY TUBERCULOSIS | 2004 |
|
RU2253460C1 |
| METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS COMBINED WITH DIABETES MELLITUS | 2023 |
|
RU2825182C1 |
| METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2015 |
|
RU2587332C1 |
